Dx&Vx
Climate Impact & Sustainability Data (2023-01 to 2023-03)
Reporting Period: 2023-01 to 2023-03
Environmental Metrics
Total Carbon Emissions:Not disclosed
Scope 1 Emissions:Not disclosed
Scope 2 Emissions:Not disclosed
Scope 3 Emissions:Not disclosed
Renewable Energy Share:Not disclosed
Total Energy Consumption:Not disclosed
Water Consumption:Not disclosed
Waste Generated:Not disclosed
Carbon Intensity:Not disclosed
ESG Focus Areas
- Not disclosed
Environmental Achievements
- Not disclosed
Social Achievements
- Not disclosed
Governance Achievements
- Not disclosed
Climate Goals & Targets
Long-term Goals:
- Not disclosed
Medium-term Goals:
- Not disclosed
Short-term Goals:
- Not disclosed
Environmental Challenges
- Decreased demand for COVID-19 diagnostic products due to the pandemic ending.
- Increased expenses due to hiring and new product launches.
Mitigation Strategies
- Expanding distribution channels for genetic analysis services.
- Strengthening CRO business.
- Developing new diagnostic kits and solutions for various diseases.
- Developing new diagnostic products based on new substances.
- Focusing on the development of new drugs and bio-healthcare products based on microbiome.
- Expanding CSO business in China and domestically.
Supply Chain Management
Supplier Audits: Not disclosed
Responsible Procurement
- Not disclosed
Climate-Related Risks & Opportunities
Physical Risks
- Not disclosed
Transition Risks
- Not disclosed
Opportunities
- Not disclosed
Reporting Standards
Frameworks Used: Null
Certifications: Null
Third-party Assurance: Not disclosed
UN Sustainable Development Goals
- Not disclosed
Not disclosed
Sustainable Products & Innovation
- Not disclosed
Awards & Recognition
- Not disclosed